VTR
Ventas, Inc.
NYSE · Real Estate · REIT - Healthcare Facilities · US
$83.56
+3.07%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.8B | 5.8B | 4.9B | 4.5B | 4.1B |
| Cost of Revenue | 6.8B | 6.2B | 2.8B | 2.6B | 2.3B |
| Gross Profit | (60.1M) | (344.2M) | 2.1B | 1.9B | 1.8B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 198.4M | 177.4M | 163.0M | 148.9M | 144.9M |
| General & Admin Expense | 198.4M | 177.4M | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (1.1B) | (1.3B) | 1.3B | 1.4B | 1.2B |
| Total Operating Expenses | (885.9M) | (1.2B) | 1.4B | 1.5B | 1.4B |
| Cost and Expenses | 6.0B | 5.0B | 4.2B | 4.1B | 3.6B |
| Operating Income (EBIT) | 825.8M | 826.8M | 681.2M | 415.5M | 483.8M |
| Non-Operating | |||||
| Interest Income | 8.3M | 22.6M | — | — | — |
| Interest Expense | 632.0M | 612.2M | 602.8M | 574.1M | 467.6M |
| Net Interest Income | (623.7M) | (589.7M) | (602.8M) | (574.1M) | (467.6M) |
| Other Non-Op Income/Expense | (612.7M) | (579.4M) | (630.7M) | (455.4M) | (541.7M) |
| Non-Operating Income (excl Interest) | (173.7M) | (32.8M) | 27.8M | (118.8M) | 74.1M |
| EBT (Pre-Tax Income) | 213.1M | 247.4M | 50.6M | (39.8M) | (57.9M) |
| Income Tax Expense | (62.0M) | (14.2M) | (37.8M) | (9.5M) | (16.9M) |
| Bottom Line | |||||
| Net Income | 265.6M | 251.4M | 81.2M | (41.0M) | (47.4M) |
| Earnings from Cont. Ops | 275.1M | 261.5M | 88.4M | (30.3M) | (40.9M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 262.1M | 251.4M | 81.2M | (41.0M) | (47.4M) |
| Per Share | |||||
| Basic EPS | $0.54 | $0.55 | $0.20 | ($0.10) | ($0.13) |
| Diluted EPS | $0.53 | $0.54 | $0.19 | ($0.10) | ($0.13) |
| Revenue Per Share | $13.20 | $12.82 | $11.96 | $11.19 | $11.06 |
| Shares | |||||
| Basic Shares Outstanding | 513.9M | 455.1M | 411.8M | 401.8M | 373.4M |
| Diluted Shares Outstanding | 518.9M | 462.6M | 416.4M | 405.7M | 373.4M |
| Profitability Metrics | |||||
| EBITDA | 2.6B | 2.2B | 1.8B | 1.7B | 1.5B |
| D&A | 1.6B | 1.4B | 1.2B | 1.2B | 1.1B |
| EBIT | 999.5M | 859.6M | 653.4M | 534.3M | 409.7M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026